Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
5mg per vial Potential For Patients seeking an alternative approach to appetite control, or those who may not tolerate GLP-1 medications well due to gastrointestinal side effects
Although a few studies touting the benefits of therapeutic riding have been published in peer-reviewed journals, they are either mainly descriptive, involve small samples or rely on poor outcome measures, and thus cannot support the therapy as a useful, evidence-based intervention
Tirzepatide 60mg key specifications Compound: Tirzepatide (dual GIP/GLP-1 receptor agonist) Strength: 60mg per vial CAS number: 2023788-19-2 Molecular formula: C 225 H 348 N 48 O 68 Molar mass: ~4810.5 g/mol Purity: 99% (HPLC, third-party verified) Form: Lyophilised powder single sealed vial Why choose the 60mg vial
People who have been properly trained on GLP-1 injection technique report that the process takes less than 30 seconds
[4] Low body weight or malnutrition : Adults with low body weight or chronic malnutrition may need lower maximum doses
US$ 24.33
US$ 24.85
US$ 29.68
